Podcasts about clinical presentation

This month we are focusing on neonatal opioid withdrawal syndrome (NOWS), with an emphasis on the underlying physiology and clinical presentation. Our host, Paul Wirkus, MD, FAAP and guest Camille Fung, MD review the mechanisms of opioid exposure and withdrawal, including neuroexcitability and the gastrointestinal and autonomic manifestations commonly seen in affected newborns. The discussion also highlights the role of specialized clinics and coordinated care models that support mothers during pregnancy and the postpartum period. Together, this episode provides a foundational understanding of NOWS to help clinicians recognize symptoms early and deliver informed, compassionate care to both infants and their families. Have a question? Email questions@vcurb.com. They will be answered in week four.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Episode Overview Join us as we venture into the stables to explore urticaria in horses - those mysterious swellings that appear seemingly out of nowhere and may disappear just as suddenly. Expert guest Dr. Valerie Fadok shares her extensive experience as both a veterinary dermatologist and immunologist to help us understand what causes these puzzling conditions, how to differentiate them from other lumps, and when to investigate further rather than automatically reaching for steroids. Featured Guest Dr. Valerie Fadok - A dual specialist bringing unique expertise as both a veterinary dermatologist and immunologist. With experience across three veterinary schools, private practice, and as a field specialist with Zoetis, Val brings a wealth of practical knowledge from working with veterinarians and horse owners around the world. Episode Breakdown Introduction to Urticaria in Horses Val discusses how horses are the most commonly affected species with urticaria among the animals veterinarians treat, and how this condition can drive both horses and their owners to distraction. The disease presents unique challenges, with sudden onset cases that sometimes resolve on their own, and chronic cases where horses experience repeated outbreaks over time. Clinical Presentation and Diagnosis What Urticaria Looks Like: Val emphasizes the importance of palpation—urticarial lesions tend to be soft compared to nodular diseases like eosinophilic granulomas Individual lesions wax and wane, even if the horse has hives every day Lesions can take fascinating shapes: round, linear, or ring-like configurations (serpiginous patterns) Not all horses with urticaria are particularly itchy Papular Urticaria: Papular (miliary) lesions are commonly associated with insect bites Val shares examples of horses moving from northern US states to Florida developing papular urticaria in their first year due to high insect pressure from mosquitoes and Culicoides These cases often resolve after the first year Sue confirms similar patterns in the UK with Culicoides Immunological vs Non-Immunological Reactions The Role of Mast Cells: Urticaria involves mast cells in the skin Immunological urticaria occurs when allergens bind to IgE on mast cells, triggering the reaction Non-immunological causes involve "twitchy" mast cells that react to physical triggers Physical Urticaria: Pressure urticaria and dermatographism—where a handprint appears on the horse's flank after touching Cold-induced urticaria Heat-induced urticaria Exercise-induced urticaria Some horses have both immunological and physical components, making diagnosis particularly challenging History is Key: Observant owners can provide crucial information (e.g., "hives appeared after training session" or "outline of saddle appeared after removal") Owner observations are often the best way to differentiate between causes Acute vs Chronic Urticaria Acute Urticaria Management: Most acute urticaria in horses is drug-related (antibiotics, pain medications) or from blood transfusions Val's approach: Don't do an intense workup immediately Treat with antihistamines (Val prefers hydroxyzine) for a few months to let mast cells settle If it recurs after stopping medication, then investigate further Sue agrees: not chronic unless present for 8+ weeks or recurring annually When to Investigate: Sue and Val agree: 8-12 weeks or recurrent episodes warrant deeper investigation Both emphasize the value of owners who keep detailed calendars noting when hives appear 50% of urticaria in people remains idiopathic—same often true for horses Competition horses present particular challenges due to medication restrictions Investigation and Testing Seasonal Cases: For seasonal urticaria, Val recommends intradermal or serum allergy testing Horses with urticaria respond well to allergen immunotherapy compared to other species Most horse owners are comfortable giving injections Non-Seasonal Cases: Consider dietary factors and whether feed changes throughout the year Horse owners are surprisingly open to food trials Val has only proven a handful of food-related urticaria cases (alfalfa and grains) Diet trials are difficult in horses, though owners are willing Environmental Allergens: House dust mites and storage mites are the most commonly identified allergens across all species Molds are important triggers, especially in humid environments Val notes regional differences: Florida has unusual pollens and insects, Texas is drier with mainly pollens, Pacific Northwest sees more mold allergies Sue observes autumn cases in UK when horses start wearing rugs, potentially related to house dust mites, temperature, dampness, or molds Allergen-Specific Immunotherapy Val's Approach: Uses traditional step-up procedure for injection immunotherapy Consults pollen charts (from Greer allergy company, pollen.com, Google searches) Selects major allergens relevant to the horse's region and history Doesn't include everything that tests positive—focuses on major allergens that fit the history Builds up from 2-3 injections per week to maintenance (once weekly to once monthly, depending on the horse) Customization is Key: Frequency depends on individual horse response Traveling horses present challenges (Val shares experience with a Budweiser Clydesdale that traveled nationwide) For traveling horses, select major allergens common across regions (cedar trees, ragweed, common grasses) Seasonal Management: Val prefers to wait until the season is over before starting immunotherapy Aims for at least 6 months of treatment before the next allergy season Backs off frequency during off-season (e.g., monthly injections) Increases frequency during active season (weekly if needed) Never stops completely during off-season to avoid starting over Sometimes "less is more"—half a milliliter every two weeks may work better than full dose every four weeks Success with Horses: Horses respond particularly well to immunotherapy compared to other species Dedicated horse owners are excellent at fine-tuning treatment based on their horse's patterns Flexibility is key: can adjust dose and frequency as needed Treatment Options Antihistamines: Val's preference: hydroxyzine (though colleague Stephen White prefers doxepin) First-line treatment when possible Corticosteroids: Most US equine vets prefer dexamethasone (less expensive) Val prefers prednisolone (learned from equine mentor at Texas A&M) Alternate-day prednisolone is useful approach Long-term dexamethasone is concerning—if needed, aim for every 3-4 days For competition horses, medication restrictions are a major consideration Off-Label Options: Apoquel has helped some difficult cases when antihistamines and steroids aren't sufficient Very expensive and off-license (requires justification) Not on horse competition drug registers (as of recording) Can be useful short-term, such as before shows Not a long-term solution Long-Term Outlook Realistic Expectations: Flares will likely be part of life even with successful immunotherapy Stress can trigger urticarial eruptions (similar to people) Hope is to avoid year-round medication, but some horses require continuous treatment for comfort Some owners relocate horses from high-allergen areas (e.g., Florida/Southeast) to northern states Education Needs: Val sees room for growth in equine veterinary use of immunotherapy Cautions against testing too early (not after just one outbreak) Healthy animals can make IgE without it being clinically relevant Need for education on proper use of testing and setting realistic expectations Horse Owner Compliance Both Val and Sue emphasize how remarkably compliant and dedicated horse owners are: Horse owners will food trial willingly Will shampoo horses twice weekly in freezing weather Keep detailed records and calendars Are observant about patterns and triggers Are open to considering food allergies Follow through consistently with immunotherapy protocols The bond between pleasure horse owners and their horses makes treatment particularly rewarding Key Takeaways Palpation matters - Soft lesions that wax and wane suggest urticaria over other nodular diseases Don't over-investigate acute cases - Wait 8-12 weeks or for recurrence before extensive workup History is everything - Detailed owner observations are invaluable for diagnosis Horses respond well to immunotherapy - Better success rates than many other species Flexibility in treatment - Adjust immunotherapy frequency and dose based on individual response 50% remain idiopathic - Many cases resolve without identifying the cause Horse owners are exceptional - Compliance and dedication make management possible

Send us a textIn this episode of PT Snacks podcast, we delve into the topic of sports hernia, also known as athletic pubalgia. Listeners will learn about what a sports hernia is, how it occurs, and the anatomy involved, including key muscles and structures. The episode covers how to assess and treat this condition based on current research and offers insights into clinical challenges and differential diagnoses. We also discusse conservative treatments, exercise progression, and when surgical intervention might be necessary, providing a comprehensive overview for physical therapists and students.00:00 Introduction to PT Snacks Podcast00:43 Understanding Sports Hernia03:55 Anatomy and Causes of Sports Hernia05:03 Clinical Presentation and Diagnosis06:42 Treatment Approaches10:29 Surgical Options and Post-Op Rehab12:02 Key Takeaways and Conclusion12:58 Additional Resources and OffersRoss JR, Stone RM, Larson CM. Core muscle injury/sports hernia/athletic pubalgia, and femoroacetabular impingement. Sports Med Arthrosc Rev. 2015;23(4):213‑220. Europe PMCDrager J, Rasio J, Newhouse A. Athletic pubalgia (sports hernia): presentation and treatment. Arthroscopy. 2020;36(12):2952‑2963.Forlizzi JM, Ward MB, Whalen J, Wuerz TH, Gill TJ 4th. Core muscle injury: evaluation and treatment in the athlete. Am J Sports Med. 2023;51(4):1087‑1095. doi:10.1177/03635465211063890. PubMedKraeutler MJ, Mei‑Dan O, Belk JW, Larson CM, Talishinskiy T, Scillia AJ. A systematic review shows high variation in terminology, surgical techniques, preoperative diagnostic measures, and geographic differences in the treatment of athletic pubalgia/sports hernia/core muscle injury/inguinal disruption. Arthroscopy. 2021;37(7):2377‑2390.e2. doi:10.1016/j.arthro.2021.03.049. PubMed+2Arthroscopy Journal+2Cohen BH, Kleinhenz DT, Schiller JR, et al. Understanding athletic pubalgia: a review. R I Med J. 2016;99(10):31‑35.Go to PT Final Exam using this link to access great studying options to conquer the NPTE!Support the showNeed CEUs? Get unlimited CEUs with MedBridge and save over $100 using code PTSNACKSPODCAST at checkout. Students: Use PTSNACKSPODCASTSTUDENT for a discounted annual plan. Studying for the NPTE? Check out PT Final Exam — they've helped thousands of students pass with confidence. Use code PTSnacks at checkout for a discount. Stay Connected! Follow so you never miss an episode. Send your questions via email to ptsnackspodcast@gmail.com Join the email list HERE Support the Show:Share the episode with someone who'd benefit. Contributing directly to the "support" link. Thanks for tuning in—your support makes this all possible!

This week, Aebhric talks with Jason Jarvis, a former Special Forces medic and current PhD candidate, and discusses Chagas disease, a tropical disease transmitted by the kissing bug. He explains the life cycle of the bug, the transmission of the disease, its clinical presentation, and the challenges in diagnosis and treatment. The conversation emphasises the importance of awareness and preventive measures, especially as Chagas disease is spreading to new regions, including parts of the United States. The discussion concludes with key take-home messages for healthcare providers and the need for ongoing education in tropical medicine.TakeawaysChagas disease is transmitted by the kissing bug, primarily in Central and South America.The life cycle of the kissing bug involves several stages, including the transmission of the parasite through its faeces.Clinical diagnosis is essential, especially in endemic areas where the disease is prevalent.The acute phase of Chagas disease is easier to treat than the chronic phase, which can lead to severe complications.Preventive measures include avoiding exposure to kissing bugs and ensuring blood products are screened for the disease.Chagas disease can also be transmitted through blood transfusions and organ transplants.Healthcare providers should be aware of the symptoms and risk factors associated with Chagas disease.The disease is now spreading to parts of the continental US, raising public health concerns.Ongoing education and awareness of tropical diseases are crucial for healthcare providers.The conversation highlights the importance of understanding the global health implications of diseases like Chagas. Chapters00:00 Introduction to Chagas Disease and Its Relevance02:36 Life Cycle of the Kissing Bug and Transmission of Chagas Disease04:58 Understanding the Pathophysiology of Chagas Disease07:31 Clinical Presentation and Diagnosis of Chagas Disease10:18 Chronic Phase and Long-term Effects of Chagas Disease12:41 Treatment Options and Challenges in Managing Chagas Disease14:51 Preventive Measures and Risk Factors for Chagas Disease17:39 Chagas Disease in the Context of Global Health19:42 Take-Home Messages for Healthcare Providers22:20 Future Considerations and Closing Thoughts

We review the diagnosis, risk stratification, & management of acute pulmonary embolism in the ED. Hosts: Vivian Chiu, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Acute_Pulmonary_Embolism.mp3 Download Leave a Comment Tags: Pulmonary Show Notes Core Concepts and Initial Approach Definition: Obstruction of pulmonary arteries, usually from a DVT in the proximal lower extremity veins (iliac/femoral), but may be tumor, air, or fat emboli. Incidence & Mortality: 300,000–370,000 cases/year in the USA, with 60,000–100,000 deaths annually. Mantra: “Don't anchor on the obvious. Always risk stratify and resuscitate with precision.” Risk Factors: Broad, including older age, inherited thrombophilias, malignancy, recent surgery/trauma, travel, smoking, hormonal use, and pregnancy. Clinical Presentation and Risk Stratification Presentation: Highly variable, showing up as anything from subtle shortness of breath to collapse. Acute/Subacute: Dyspnea (most common), pleuritic chest pain, cough, hemoptysis, and syncope. Patients are likely tachycardic, tachypneic, hypoxemic on room air, and may have a low-grade fever. Chronic: Can mimic acute symptoms or be totally asymptomatic. Pulmonary Infarction Signs: Pleuritic pain, hemoptysis, and an effusion. High-Risk Red Flags: Signs of hypotension (systolic blood pressure < 90 mmHg for over 15 minutes),

Send us a textIn today's episode of PTs Snacks podcast, hosted by Kasey, we dive into the intricacies of high ankle sprains, also known as syndesmotic ankle sprains. We'll explore the relevant anatomy, common mechanisms of injury, diagnostic techniques, and treatment strategies. Kasey also highlights the importance of distinguishing high ankle sprains from other types of ankle injuries and discusses both non-surgical and surgical management approaches. Whether you're a seasoned physical therapist or a student, this episode is packed with valuable insights to enhance your clinical practice.00:00 Introduction to PTs Snacks Podcast00:19 Understanding High Ankle Sprains00:56 Anatomy Review: Syndesmotic Ligaments03:43 Mechanism of Injury05:29 Clinical Presentation and Diagnosis06:43 Stress Tests for High Ankle Sprains08:29 Imaging and Differential Diagnoses09:30 Treatment and Rehabilitation Stages11:43 Prognosis and Final Thoughts12:19 Special Offers and ConclusionGo to PT Final Exam using this link to access great studying options to conquer the NPTE!Support the showStay Connected! Make sure to hit follow now so you don't miss an episode! Got questions? Email me at ptsnackspodcast@gmail.com or leave feedback HERE. You can also join the email list HERE Need CEUs Fast?Time and resources short? Medbridge has you covered: Get over $100 off a subscription with code PTSNACKSPODCAST: Medbridge Students: Save $75 off a student subscription with code PTSNACKSPODCASTSTUDENT—a full year of unlimited access for less! Prepping for the NPTE? Get all the study tools you need to master it at PT Final Exam. Use code PTSnacks at checkout to get a discount! Want to Support the Show?Help me keep creating free content by: Sharing the podcast with someone who'd benefit. Contributing directly via the link...

Join us in this episode of PT Snacks podcast as we dive into Thoracic Outlet Syndrome (TOS). This episode explores the causes, types, and diagnostic criteria of TOS. It includes an overview of provocation tests, symptom patterns, and potential treatment strategies, emphasizing the importance of ruling out other diagnoses. Additional resources and further reading options are provided for those wanting to expand their knowledge.00:00 Introduction to Thoracic Outlet Syndrome00:46 Understanding Thoracic Outlet Syndrome01:32 Types of Thoracic Outlet Syndrome02:35 Diagnosing Thoracic Outlet Syndrome03:51 Clinical Presentation and Symptoms05:06 Differential Diagnosis06:22 Physical Therapy Management08:04 When to Refer for Surgery08:53 Key Takeaways and ResourcesHock, G., Johnson, A., Barber, P., & Papa, C. (2022). Current Clinical Concepts: Rehabilitation of Thoracic Outlet Syndrome.. Journal of athletic training. https://doi.org/10.4085/1062-6050-138-22.Jones, M., Prabhakar, A., Viswanath, O., Urits, I., Green, J., Kendrick, J., Brunk, A., Eng, M., Orhurhu, V., Cornett, E., & Kaye, A. (2019). Thoracic Outlet Syndrome: A Comprehensive Review of Pathophysiology, Diagnosis, and Treatment. Pain and Therapy, 8, 5 - 18. https://doi.org/10.1007/s40122-019-0124-2.Support the showWhy PT Snacks Podcast?This podcast is your go-to for bite-sized, practical info designed for busy, overwhelmed Physical Therapists and students who want to build confidence in their foundational knowledge without sacrificing life's other priorities. Stay Connected! Never miss an episode—hit follow now! Got questions? Email me at ptsnackspodcast@gmail.com or leave feedback HERE. Join the email list HERE On Instagram? Find unique content at @dr.kasey.hankins! Need CEUs Fast?Time and resources short? Medbridge has you covered: Get over $100 off a subscription with code PTSNACKSPODCAST: Medbridge Students: Save $75 off a student subscription with code PTSNACKSPODCASTSTUDENT—a full year of unlimited access for less!(These are affiliate links, but I only recommend Medbridge because it's genuinely valuable.) Optimize Your Patient Care with Tindeq: Get 10% off with code PTSNACKS10: [Tindeq] ...

Featuring perspectives from Dr Farshid Dayyani, Ms Caroline Kuhlman, Dr Philip A Philip and Ms Amanda K Wagner, including the following topics: Introduction: Initial Management of Pancreatic Adenocarcinoma (PAD) (0:00) Clinical Presentation and Prognosis of PAD; Recent Advances in Up-Front Treatment for Metastatic PAD (19:01) Selection and Sequencing of Therapy for Relapsed/Refractory Metastatic PAD (54:38) Importance of Palliative Care for Advanced PAD (1:06:09) Role of PARP Inhibitor Maintenance Therapy for Newly Diagnosed Metastatic PAD (1:14:59) Promising Investigational Strategies for PAD (1:26:56) NCPD information and select publications

This week we talk to Dr Amy Webster, a consultant haematologist in Leicester and head of the haemoglobinopathy service here.We talk about the pathophysiology behind the disease this week, as well as the varying ways patients present. We also cover some of the challenges patients face in hospital getting the treatment they need. Be sure to tune in!Also check out our link tree for q feedback questionnaire and our discord server!https://linktr.ee/memcast?fbclid=PAZXh0bgNhZW0CMTEAAae8FiKiVcddms52uynYTAD0AKMj3DV6RGWExS-o9nh9OfV6pffVefR0W0JzHA_aem_Az35qkAICNmbNHGPP66DPw

We dive into the recognition and management of blast crisis. Hosts: Sadakat Chowdhury, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Blast_Crisis.mp3 Download Leave a Comment Tags: Hematology, Oncology Show Notes Topic Overview Blast crisis is an oncologic emergency, most commonly seen in chronic myeloid leukemia (CML). Defined by: >20% blasts in peripheral blood or bone marrow. May include extramedullary blast proliferation. Without treatment, median survival is only 3–6 months. Pathophysiology & Associated Conditions Usually occurs in CML, but also in: Myeloproliferative neoplasms (MPNs) Myelodysplastic syndromes (MDS) Transition from chronic to blast phase often reflects disease progression or treatment resistance. Risk Factors 10% of CML patients progress to blast crisis. Risk increased in: Patients refractory to tyrosine kinase inhibitors (e.g., imatinib). Those with Philadelphia chromosome abnormalities. WBC >100,000, which increases risk for leukostasis. Clinical Presentation Symptoms often stem from pancytopenia and leukostasis: Anemia: fatigue, malaise. Functional neutropenia: high WBC count, but increased infection/sepsis risk. Thrombocytopenia: bleeding, bruising. Leukostasis/hyperviscosity effects by system: Neurologic: confusion, visual changes, stroke-like symptoms. Cardiopulmonary: ARDS, myocardial injury. Others: priapism, limb ischemia, bowel infarction.

Diarrhea is one of the more common concerns in emergency medicine worldwide and in the United States, yet we often do not spend enough time understanding the breadth of causes and considerations for this syndrome. Do you know which patients benefit from Zinc? Would you like to review HUS? Can you mixup Oral Rehydration Solution if you needed to? We cover all of this and more in this “code brown” of a chapter! So come, get dirty with Alex and Venk in this truly crappy chapter of Always on EM!   CONTACTS X - @AlwaysOnEM; @VenkBellamkonda YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch Email - AlwaysOnEM@gmail.com REFERENCES & LINKS Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, Cantey J, Pickering LK. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-e80. doi: 10.1093/cid/cix669. PMID: 29053792; PMCID: PMC5850553. Gore JI, Surawicz C. Severe acute diarrhea. Gastroenterol Clin North Am. 2003 Dec;32(4):1249-67. doi: 10.1016/s0889-8553(03)00100-6. PMID: 14696306; PMCID: PMC7127018. Freedman SB, van de Kar NCAJ, Tarr PI. Shiga Toxin–Producing Escherichia coli and the Hemolytic–Uremic Syndrome. The New England Journal of Medicine. 2023;389(15):1402-1414. doi:10.1056/NEJMra2108739. Logan C, Beadsworth MB, Beeching NJ. HIV and diarrhoea: what is new? Curr Opin Infect Dis. 2016 Oct;29(5):486-94. doi: 10.1097/QCO.0000000000000305. PMID: 27472290. Chassany O, Michaux A, Bergmann JF. Drug-induced diarrhoea. Drug Saf. 2000 Jan;22(1):53-72. doi: 10.2165/00002018-200022010-00005. PMID: 10647976. Schiller LR. Secretory diarrhea. Curr Gastroenterol Rep. 1999 Oct;1(5):389-97. doi: 10.1007/s11894-999-0020-8. PMID: 10980977. Gong Z, Wang Y. Immune Checkpoint Inhibitor-Mediated Diarrhea and Colitis: A Clinical Review. JCO Oncol Pract. 2020 Aug;16(8):453-461. doi: 10.1200/OP.20.00002. Epub 2020 Jun 25. PMID: 32584703. Do C, Evans GJ, DeAguero J, Escobar GP, Lin HC, Wagner B. Dysnatremia in Gastrointestinal Disorders. Front Med (Lausanne). 2022 May 13;9:892265. doi: 10.3389/fmed.2022.892265. PMID: 35646996; PMCID: PMC9136014. Expert Panel on Gastrointestinal Imaging; Chang KJ, Marin D, Kim DH, Fowler KJ, Camacho MA, Cash BD, Garcia EM, Hatten BW, Kambadakone AR, Levy AD, Liu PS, Moreno C, Peterson CM, Pietryga JA, Siegel A, Weinstein S, Carucci LR. ACR Appropriateness Criteria® Suspected Small-Bowel Obstruction. J Am Coll Radiol. 2020 May;17(5S):S305-S314. doi: 10.1016/j.jacr.2020.01.025. PMID: 32370974. Rami Reddy SR, Cappell MS. A Systematic Review of the Clinical Presentation, Diagnosis, and Treatment of Small Bowel Obstruction. Curr Gastroenterol Rep. 2017 Jun;19(6):28. doi: 10.1007/s11894-017-0566-9. PMID: 28439845. Modahl L, Digumarthy SR, Rhea JT, Conn AK, Saini S, Lee SI. Emergency department abdominal computed tomography for nontraumatic abdominal pain: optimizing utilization. J Am Coll Radiol. 2006 Nov;3(11):860-6. doi: 10.1016/j.jacr.2006.05.011. PMID: 17412185. Scheirey CD, Fowler KJ, Therrien JA, et al. ACR Appropriateness Criteria Acute Nonlocalized Abdominal Pain. Journal of the American College of Radiology : JACR. 2018;15(11S):S217-S231. doi:10.1016/j.jacr.2018.09.010. Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol. 2009 Oct;104(10):2596-604; quiz 2605. doi: 10.1038/ajg.2009.329. Epub 2009 Jun 23. PMID: 19550407. Musekiwa A, Volmink J. Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions. Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003754. doi: 10.1002/14651858.CD003754.pub3. PMID: 22161381; PMCID: PMC6532622. Centers for Disease Control and Prevention (CDC). Scombroid fish poisoning associated with tuna steaks--Louisiana and Tennessee, 2006. MMWR Morb Mortal Wkly Rep. 2007 Aug 17;56(32):817-9. PMID: 17703171. Résière D, Florentin J, Mehdaoui H, Mahi Z, Gueye P, Hommel D, Pujo J, NKontcho F, Portecop P, Nevière R, Kallel H, Mégarbane B. Clinical Characteristics of Ciguatera Poisoning in Martinique, French West Indies-A Case Series. Toxins (Basel). 2022 Aug 3;14(8):535. doi: 10.3390/toxins14080535. PMID: 36006197; PMCID: PMC9415704. Centers for Disease Control and Prevention (CDC). Ciguatera fish poisoning--Texas, 1998, and South Carolina, 2004. MMWR Morb Mortal Wkly Rep. 2006 Sep 1;55(34):935-7. PMID: 16943762. Thyroid Inferno EM Blog: https://emblog.mayo.edu/2014/11/01/thyroid-inferno/  Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev. 2016 Dec 20;12(12):CD005436. doi: 10.1002/14651858.CD005436.pub5. PMID: 27996088; PMCID: PMC5450879. Dhingra U, Kisenge R, Sudfeld CR, Dhingra P, Somji S, Dutta A, Bakari M, Deb S, Devi P, Liu E, Chauhan A, Kumar J, Semwal OP, Aboud S, Bahl R, Ashorn P, Simon J, Duggan CP, Sazawal S, Manji K. Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial. N Engl J Med. 2020 Sep 24;383(13):1231-1241. doi: 10.1056/NEJMoa1915905. PMID: 32966722; PMCID: PMC7466932. Dalfa RA, El Aish KIA, El Raai M, El Gazaly N, Shatat A. Oral zinc supplementation for children with acute diarrhoea: a quasi-experimental study. Lancet. 2018 Feb 21;391 Suppl 2:S36. doi: 10.1016/S0140-6736(18)30402-1. Epub 2018 Feb 21. PMID: 29553435.   WANT TO WORK AT MAYO? EM Physicians: https://jobs.mayoclinic.org/emergencymedicine EM NP PAs: https://jobs.mayoclinic.org/em-nppa-jobs   Nursing/Techs/PAC: https://jobs.mayoclinic.org/Nursing-Emergency-Medicine EMTs/Paramedics: https://jobs.mayoclinic.org/ambulanceservice All groups above combined into one link: https://jobs.mayoclinic.org/EM-Jobs

I'm really excited to introduce today's guest, Dr. Pejman Katiraei!Mold exposure can have a profound impact on children's health, especially for kids with Autism Spectrum Disorder (ASD) and Pediatric Acute Neuropsychiatric Syndrome (PANS). In this episode, Dr. Pejman Katiraei shares his in-depth mold protocol designed specifically for children dealing with these complex conditions.

Which of the following is most consistent with the clinical presentation of a person with folate-deficiency anemia? A. A 45-year-old woman with uterine fibroids, menorrhagia and a microcytic, hypochromic anemia with elevated RDW B. A 35-year-old woman with newly diagnosed systemic lupus and a normocytic, normochromic anemia with NL RDW C. A 40-year-old woman with alcohol use disorder who drinks 5-6 glasses of wine per day and a macrocytic normocytic anemia with an elevated RDW D. A 65 yo woman with a 20 year-history of hypothyroidism presenting with a 6-month history of stocking-glove neuropathy and a macrocytic, normochromic anemia with an elevated RDW.  ---YouTube: https://www.youtube.com/watch?v=VsxbJMBLd4U&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=111Visit fhea.com to learn more!

Episode 183: Colorectal Cancer in Young AdultsFuture Dr. Avila and Dr. Arreaza present evidence-based information about the screening and diagnosis of colorectal cancer and explain the increasing incidence among young adult and the importance to screen early in high risk groups.  Written by Jessica Avila, MS4, American University of the Caribbean School of Medicine. Edits and comments by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.IntroductionJessica: Although traditionally considered a disease only affecting older adults, colorectal cancer (CRC) has increasingly impacted younger adults (defined as those under 50) at an alarming rate. According to the American Cancer Society, CRC is now the leading cause of cancer-related death in men under 50 and the second leading cause in women under 50 (American Cancer Society, 2024). Arreaza: Why were you motivated to talk about CRC in younger patients?Jessica: Because despite advancements in early detection and treatment, younger patients are often diagnosed at later stages, resulting in poorer outcomes. We will discuss possible causes, risk factors, common symptoms, and why early screening and prevention are important. Arreaza: This will be a good reminder for everyone to screen for colorectal cancer because 1 out of every 5 cases of colorectal cancer occur in adults between the ages of 20 and 54. The Case of Chadwick BosemanJessica: Many people know Chadwick Boseman from his role as T'Challa in Black Panther. His story highlights the worrying trend of increasing CRC in young adults. He was diagnosed with stage III colorectal cancer at age 39. This diagnosis was not widely known until he passed away at 43. His case shows how silent and aggressive young-onset CRC can be. Like many young adults with CRC, his symptoms may have been missed or thought to be less serious issues. His death drew widespread attention to the rising burden of CRC among young adults and emphasized the critical need for increased awareness and early screening efforts.Arreaza: Black Panther became a hero not only in the movie, but also in real life, because he raised awareness of the problem in young AND in Black adults. EpidemiologyJessica: While rates of CRC in older populations have decreased since the 1990s, adults under 50 have seen an increase in CRC rates of nearly 50%. (Siegel et al., 2023). Currently, one in five new CRC diagnoses occurs in individuals younger than 55 (American Cancer Society, 2024).Arreaza: What did you learn about the incidence by ethnic groups? Are there any trends? Jessica: Yes, certain ethnic groups are shown to have higher rates of CRC. Black Americans, Native Americans, and Alaskan Natives have the highest incidence and mortality rates from CRC (American Cancer Society, 2024). Black Americans have a 20% higher incidence and a 40% higher mortality rate from CRC compared to White Americans, primarily due to disparities in access to screening, healthcare resources, and early diagnosis. Hispanic and Asian American populations are also experiencing increasing CRC rates, though to a lesser extent.Arreaza: It is important to highlight that Black Americans have the highest rate of both diagnoses and deaths of all groups in the United States. Who gets colorectal cancer?Risk FactorsJessica: Anyone can get colorectal cancer, but some are at higher risk. In most cases, environmental and lifestyle factors are to blame, but early-onset CRC are linked to hereditary conditions. Arreaza: There is so much to learn about colorectal cancer risk factors. Tell us more.Jessica: The following are key risk factors:Modifiable risk factors:Diet and processed foods: A diet high in processed meats, red meat, refined sugars, and low fiber is strongly associated with an increased risk of CRC. Fiber is essential for gut health, and its deficiency has been linked to increased colorectal cancer risk (Dekker et al., 2023).Obesity and sedentary lifestyle: Obesity and physical inactivity contribute to CRC risk by promoting chronic inflammation, insulin resistance, and metabolic disturbances that promote tumor growth (Stoffel & Murphy, 2023).Gut microbiome imbalance: Disruptions in gut microbiota, especially an overgrowth of Fusobacterium nucleatum, have been noted in CRC pathogenesis, potentially causing tumor development and progression (Brennan & Garrett, 2023).Arreaza: As a recap, processed foods, obesity, sedentarism, and gut microbiome. We also have to mention smoking and high alcohol consumption as major risks factors, but the strongest risk factor is a family history of the disease.Non-modifiable risk factors:Genetic predisposition: Although only 20% of early-onset CRC cases are linked to hereditary syndromes such as Lynch syndrome and familial adenomatous polyposis (FAP), individuals with a first-degree relative with CRC are at a significantly higher risk and should undergo earlier and more frequent screening (Stoffel & Murphy, 2023).Arreaza: Also, there is a difference in incidence per gender assigned at birth, which is also not modifiable. The rate in the US was 33% higher in men (41.5 per 100,000) than in women (31.2 per 100,000) during 2015-2019. So, if you are a man, your risk for CRC is slightly higher. Protective factors, according to the ACS, are physical activity (no specification about how much and how often) and dairy consumption (400g/day). Jessica, let's talk about how colon cancer presents in our younger patients.Clinical Presentation and Challenges in DiagnosisJessica: Young-onset CRC is often diagnosed at advanced stages due to delayed recognition of symptoms. Common symptoms include:Rectal bleeding (often mistaken for hemorrhoids)Young individuals may ignore it, believe they do not have time to address it, or lack insurance to cover a comprehensive evaluation.Unexplained weight lossFatigue or weaknessChanges in bowel habits (persistent diarrhea or constipation)This may also be rationalized by dietary habits.Abdominal pain or bloatingIron deficiency anemia.Arreaza: All those symptoms can also be explained by benign conditions, and colorectal cancer can often be present without clear symptoms in its early stages. Jessica: Yes, in young adults, symptoms may be dismissed by healthcare providers as benign conditions such as irritable bowel syndrome (IBS), hemorrhoids, or dietary intolerance, leading to significant diagnostic delays. Arreaza: We must keep a low threshold for ordering a colonoscopy, especially in patients with the risks we mentioned previously. Jessica: We may also be concerned about the risk/benefit of colonoscopy or diagnostic methods in younger adults, given the traditional low likelihood of CRC. Approximately 58% of young CRC patients are diagnosed at stage III or IV, compared to 43% of older adults (American Gastroenterological Association, 2024). Early recognition and prompt evaluation of persistent symptoms are crucial for improving outcomes. Empowering and informing young adults about concerning symptoms is the first step in better recognition and better outcomes for these individuals.Arreaza: This is when the word “follow up” becomes relevant. I recommend you leave the door open for patients to return if their common symptoms worsen or persist. Let's talk about screening. Screening and PreventionJessica: Due to the trend of CRC being identified in younger populations, the U.S. Preventive Services Task Force (USPSTF) lowered the recommended screening age for CRC from 50 to 45 in 2021 (USPSTF, 2021). Off the record, some Gastroenterologists also foresee the USPSTF lowering the age to 40. Arreaza: That is correct, it seems like everyone agrees now that the age to start screening for average-risk adults is 45. It took a while until everyone came to an agreement, but since 2017, the US Multi-Society Task Force had recommended screening at age 45, the American Cancer Society recommended the same age (45) in 2018, and the USPSTF recommended the same age in 2021. This podcast is a reminder that the age of onset has been decreased from 50 to 45, for average-risk patients, according to major medical associations.Jessica: For individuals with additional risk factors, including a family history of CRC or chronic gastrointestinal symptoms, screening starts at age 40 or 10 years before the diagnosis of colon cancer in a first-degree relative. Dr. Arreaza, who has the lowest and the highest rate of screening for CRC in the US? Arreaza: The best rate is in Massachusetts (70%) and the lowest is California (53%). Let's review how to screen:Jessica: Recommended Screening Methods:Colonoscopy: Considered the gold standard for CRC detection and prevention, colonoscopy allows for identifying and removing precancerous polyps.Fecal Immunochemical Test (FIT): A non-invasive stool test that detects hidden blood, recommended annually.Stool DNA Testing (e.g., Cologuard): This test detects genetic mutations associated with CRC and is recommended every three years.Arreaza: Computed tomographic colonography (CTC) is another option, it is less common because it is not covered by all insurance plans, it examines the whole colon, it is quick, with no complications. Conclusion:Colorectal cancer is rapidly emerging as a serious health threat for young adults. The increase in cases over the past three decades highlights the urgent need for increased awareness, early symptom detection, and proactive screening. While healthcare providers must weigh the risk/benefit of testing for CRC in younger adults, patients must also be equipped with knowledge of concerning signs so that they may also advocate for themselves. Early detection remains the most effective tool in preventing and treating CRC, emphasizing the importance of screening and risk factor modification.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:American Cancer Society. (2024). Colorectal Cancer Statistics, 2024. Retrieved fromhttps://www.cancer.orgAmerican Gastroenterological Association. (2024). Delays in Diagnosis of Young-Onset Colorectal Cancer: A Systemic Issue. Gastroenterology Today.Brennan, C. A., & Garrett, W. S. (2023). Gut Microbiota and Colorectal Cancer: Advances and Future Directions. Gastroenterology.Dekker, E., et al. (2023). Colorectal Cancer in Adolescents and Young Adults: A Growing Concern. The Lancet Gastroenterology & Hepatology.Siegel, R. L., et al. (2023). Colorectal Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians.Stoffel, E. M., & Murphy, C. C. (2023). Genetic and Environmental Risk Factors in Young-Onset Colorectal Cancer. JAMA Oncology.U.S. Preventive Services Task Force. (2021). Colorectal Cancer Screening Guidelines.Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

In this episode of the PFC Podcast, Dennis speaks with Dr. Ryan Maves, an infectious disease physician, about dengue fever, a significant tropical disease. They discuss the epidemiology, clinical presentation, management, and prevention strategies for dengue, emphasizing the importance of recognizing warning signs and providing supportive care. Dr. Maves shares insights from his extensive experience in tropical medicine, particularly during his time in the Navy and in Peru, where he conducted research on dengue and other vector-borne diseases. The conversation highlights the increasing relevance of dengue in both civilian and military contexts, especially in light of climate change and urbanization. Takeaways Dengue fever is part of the flavivirus family, which includes Zika and chikungunya. The disease is primarily transmitted by the Aedes aegypti mosquito, which thrives in urban areas. Dengue can cause severe morbidity, particularly in non-endemic populations. Management of dengue is largely supportive, with a focus on fluid resuscitation. Warning signs of severe dengue include persistent vomiting, abdominal pain, and altered mental status. Preventive measures include using insect repellent and controlling standing water. Dengue is endemic in many tropical regions, including parts of Latin America and Southeast Asia. Vaccines for dengue exist but are not widely available for adults. Dengue can present with a wide spectrum of symptoms, making diagnosis challenging. Public health strategies are crucial in controlling dengue outbreaks. Chapters 00:00 Introduction to Tropical Medicine and Dengue Fever 03:12 Understanding Dengue Fever: Background and Epidemiology 06:03 Clinical Presentation and Diagnosis of Dengue Fever 08:56 Management and Treatment of Dengue Fever 11:54 Warning Signs and Severe Dengue 15:13 Preventive Measures and Public Health Strategies 18:01 Final Thoughts on Dengue and Tropical Medicine Thank you to Delta Development Team for in part, sponsoring this podcast. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠deltadevteam.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ For more content go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠ Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care

Summary In this episode of the Future of Dermatology podcast, Dr. Faranak Kamangar speaks with Mitchell Hanson, a medical student and researcher, about the intersection of dermatology, sexual health, and public health. They discuss the importance of modernizing sexual health history taking, the impact of MPOX on sexual and gender minorities, and the role of trust in patient care. The conversation also highlights the significance of vaccination efforts and the integration of art and advocacy in dermatology. Mitchell shares his vision for the future of dermatology, emphasizing the need for effective communication and engagement with the public through media. Articles mentioned in this podcast: https://practicaldermatology.com/topics/feature/advancing-sexual-health-histories-in-dermatology-a-modernized-comprehensive-approach-for-diverse-populations/28864/  https://www.greaterthan.org/campaigns/mpox/ https://www.nejm.org/doi/full/10.1056/NEJMp2407068   Takeaways Dermatology has deep roots in public health and sexual health education. Building trust with patients is essential for effective care. Modernizing sexual health history taking is crucial for accurate diagnoses. MPOX has significant implications for sexual and gender minorities. Vaccination efforts are vital in controlling public health threats like MPOX. Art can serve as a powerful tool for advocacy in dermatology. Health equity must be prioritized in dermatological practices. Education is key to dispelling misinformation about vaccines. Engaging with media can enhance public understanding of dermatology. The future of dermatology lies in innovative ideas and community involvement.   Chapters 00:00 - Introduction to Dermatology and Guest Background 02:48 - The Importance of Sexual Health in Dermatology 05:59 - Building Trust with Patients 09:08 - Modernizing Sexual Health History Taking 11:46 - Understanding MPOX and Its Impact 14:56 - Clinical Presentation and Diagnosis of MPOX 18:09 - Public Health Response and Vaccination Efforts 20:56 - Art and Advocacy in Dermatology 23:46 - Future of Dermatology and Media Engagement

We discuss the recognition and treatment of necrotizing fasciitis. Hosts: Aurnee Rahman, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Necrotizing_Fasciitis.mp3 Download Leave a Comment Tags: Critical Care, General Surgery Show Notes Table of Contents 0:00 – Introduction 0:41 – Overview 1:10 – Types of Necrotizing Fasciitis 2:21 – Pathophysiology & Risk Factors 3:16 – Clinical Presentation 4:06 – Diagnosis 5:37 – Treatment 7:09 – Prognosis and Recovery 7:37 – Take Home points Introduction Necrotizing soft tissue infections can be easily missed in routine cases of soft tissue infection. High mortality and morbidity underscore the need for vigilance. Definition A rapidly progressive, life-threatening infection of the deep soft tissues. Involves fascia and subcutaneous fat, causing fulminant tissue destruction. High mortality often due to delayed recognition and treatment. Types of Necrotizing Fasciitis Type I (Polymicrobial) Involves aerobic and anaerobic organisms (e.g., Bacteroides, Clostridium, Peptostreptococcus). Common in immunocompromised patients or those with comorbid...

Chronic fatigue and long covid symptoms explained with solutions with functional medicine and MD Dr. April Lind. (3:11) Planned Parenthood exposed negotiating with and in partnership with UCSD for research on aborted baby body parts (33:50) Phasing into Christmas/Advent and Christmas decorations to be continued... (48:16) Resources mentioned :  Dr. April Lind's website: https://mnpersonalizedmedicine.com/   Strength Training and anti aging hacks  https://omny.fm/shows/trending-with-timmerie-catholic-principles-applied/anti-aging-hacks-strength-training   Institute of functional medicine  https://www.ifm.org/find-a-practitioner/   Academy of Intregrative Health and Medicine  https://members.aihm.org/find-a-provider/   Research on long covid and MECFS Mitochondria and chronic disease Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases? - PMC   The Key Role of Mitochondrial Function in Health and Disease - PMC   Mitochondrial dynamics in health and disease: mechanisms and potential targets | Signal Transduction and Targeted Therapy Mitochondrial dysfunction: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy EBV Is there a link between long COVID and Epstein-Barr virus?   Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation - PMC   The Long COVID Puzzle: Autoimmunity, Inflammation, and Other Possible Causes > News > Yale Medicine Long covid mcas Mast cell activation symptoms are prevalent in Long-COVID - PMC Mast cell activation syndrome and the link with long COVID - PubMed Mast cell activation syndrome: An up-to-date review of literature - PMC   Long covid and me/cfs Long COVID, ME/CFS and the Importance of Studying Infection-Associated Illnesses > News > Yale Medicine Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—A Systemic Review and Comparison of Clinical Presentation and Symptomatology - PMC ME/CFS and Post-Exertional Malaise among Patients with Long COVID - PMC The overlapping conditions of Long Covid and ME/CFS | The BMJ Planned Parenthood exposed negotiating with and in partnership with UCSD for research on aborted baby body parts https://www.centerformedicalprogress.org/2024/11/breaking-viable-nonanomalous-6-month-old-fetuses-sold-from-planned-parenthood-abortions-to-university-of-california-new-documents-show/  

Mpox is an evolving global health threat, and clinicians should be aware of characteristic signs and symptoms to ensure timely diagnosis and appropriate management. Author Jason Zucker, MD, MS, of Columbia University Irving Medical Center speaks with JAMA Deputy Editor Preeti Malani, MD, MSJ, about the transmission, diagnosis, management, and prevention of mpox. Related Content: Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies The Resurgence of Mpox in Africa Decline of Mpox Antibody Responses After Modified Vaccinia Ankara–Bavarian Nordic Vaccination WHO Announces Mpox Global Plan, Appeals for Funding

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on impact of the noninvasive diagnostic algorithm on clinical presentation and prognosis in cardiac amyloidosis.

Featuring perspectives from Dr Thierry Alcindor and Dr Mrinal Gounder, including the following topics: Introduction: Biology and Clinical Presentation (0:00) Case: A man in his mid 60s with desmoid fibromatosis — Dr Alcindor (12:36) Tyrosine Kinase Inhibitors (24:51) Gamma Secretase Inhibitors (31:02) Case: A woman in her early 40s with desmoid tumor treated with a gamma secretase inhibitor on a clinical trial — Dr Gounder (46:09) Case: A woman in her late 30s with a large groin desmoid tumor — Dr Gounder (51:52) Case: A woman in her early 30s with desmoid fibromatosis requiring treatment — Dr Alcindor (54:50) CME information and select publications

Drs. Avery Tung and Brittney Williams discuss the article “Sepsis-Induced Coagulopathy: A Comprehensive Narrative Review of Pathophysiology, Clinical Presentation, Diagnosis, and Management Strategies” published in the April 2024 issue of Anesthesia & Analgesia.

The extraterrestrial comedy podcast where we probe penis-snatching. Mr Moonwalker today makes the choice that Kev in the John, never, had. Twice. In 2023 Nigeria, the most awful of pandemic's broke out. Worse than life-ending disease, this pandemic resulted in people temporarily losing their penis. It's not just d*cks either, for some folks were losing nipples. These incidents have resulted in much pain and suffering via mob justice. There have also been police prosecutions related to these cases of vanishing penis. Alongside these horrific events we ponder whether a micropenis is the size of a nose? If you had the power to inflict people with a micro-organ, would you use it? Ultimately we ask whether this unusual epidemic was a case of aliens, a cryptid, demons, voodoo, a ghost, or telekinesis? Then we give Mr Moonwalker a gift he will never forget. All that and more on this week's file.     Patreon: https://www.patreon.com/butitwasaliens   Store: https://butitwasaliens.co.uk/shop/     Probe us: Email: butitwasaliens@gmail.com Instagram/Threads @ ButItWasAliens Twitter @ ButItWasAliens Facebook: @ ButItWasAliens - join Extraterrestrial Towers     Music:  Music created via Garageband. Additional music via: https://freepd.com - thank you most kindly good people. We closed out the episode with the 'Staff Roll' aka credits theme from Nintendo's 1990-1992 Super Mario World from the Super Nintendo Entertainment System, composed by Hero of Sound Kōji Kondō.    Drinking rules: Kev filled the research notes with photos and artwork of the common human penis. Many, many hogs. These hogs were not directly referenced in the research, they were just hanging around. Every time Mr Moonwalker commented on any such image, he had to do a shot aka a mini-Moonie.     Sources: New Lines Magazine article by Kingsley Charles: https://newlinesmag.com/reportage/the-curious-phenomenon-of-nigerias-disappearing-penises/   Wikipedia summary (yes, we know): https://en.m.wikipedia.org/wiki/Koro_(disease)    Strong, Y. N., Cao, D. Y., Zhou, J., Guenther, M.A., Anderson, D.J., Kaye, A. D., Blick, B. E., Anandi, P. R., Patel, H. Y. and Urits, I. (2023) Koro Syndrome: Epidemiology, Psychiatric and Physical Risk Factors, Clinical Presentation, Diagnosis, and Treatment Options. Health Psychology Research. 11: 70165. Available online at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946797/ Accessed: 22/01/2024

Music: Spark Of Inspiration by Shane Ivers - https://www.silvermansound.comLicensed under Creative Commons Attribution 4.0 International Licensehttps://creativecommons.org/licenses/by/4.0/Music promoted by https://www.chosic.com

Commentary by Dr. Valentin Fuster

In this episode, Angela Branche, MD; Pamela Rockwell, DO, FAAFP; and Richard Zimmerman, MD, MPH, FAAFP, discuss the clinical presentation of RSV in older adults and available diagnostic tests for RSV, including: Comparison of RSV clinical symptoms to influenza and COVID-19, including differentiating symptoms at infection onsetRSV disease progression RSV diagnostic approaches How RSV diagnosis of adults may differ from diagnosis of childrenClinical considerations for RSV testingHow to improve RSV awareness among patientsProgram Director:Pamela Rockwell, DO, FAAFPProfessorFamily MedicineUniversity of Michigan Medical SchoolAnn Arbor, MichiganFaculty:Angela Branche, MDAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkRichard Zimmerman, MD, MPH, FAAFPProfessorDepartment of Family Medicine and Clinical Epidemiology University of PittsburghPittsburgh, PennsylvaniaContent based on an online CME program supported by an independent educational grant from GlaxoSmithKline.Link to full program:https://bit.ly/49YBZ4rLink to downloadable slides: https://bit.ly/3GocjRe

CardioNerds join Dr. Tony Li Yi Wei, Dr. Rodney Soh Yu Hang, and Dr. Zan Ng Zhe Yan from the National University Heart Centre Singapore for a cocktail drink on the top of marina bay sands. They discuss the following case featuring a young woman with recurrent ACS ultimately found to have Takayasu Arteritis. The ECPR for this episode is provided by Dr. Teng Gim Gee and Professor Tan Huay Cheem. Episode audio was edited by student Dr. Shivani Reddy. A 37-year-old woman presents with chest pain. She has a background history of Hashimoto thyroiditis, gestational diabetes, and anemia of chronic disease and possible iron deficiency. Her significant medical history includes ischemic heart disease with prior coronary angiogram showing triple vessel coronary artery disease for which she underwent coronary artery bypass graft surgery (CABG) with LIMA-LAD, SVG-OM, SVG-RCA. After CABG, she had recurrent admissions in the subsequent year with acute coronary syndromes where she underwent percutaneous coronary intervention (PCI) to SVG-OM, RI, proximal LAD, and distal LAD. She was a non-smoker and had been compliant with her medications. For her current presentation, she underwent myocardial perfusion imaging which showed a large sized area of inducible ischemia in the LCx territory.  Repeat coronary evaluation showed occluded SVG-OM, occluded LIMA-LAD where she underwent PCI. Clinically, she was noted to have weak brachial and radial pulses on the left side with systolic blood pressure difference between both arms. CT Thoracic Angiogram demonstrated concern for underlying large vessel vasculitis such as Takayasu arteritis. ESR was elevated at 34. Rheumatology was consulted and she was diagnosed with Takayasu arteritis and started on prednisolone and azathioprine. Given her young age, absence of traditional atherosclerotic risk factors, and progressive coronary disease, Takayasu arteritis was deemed the underlying etiology of her coronary disease. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Case Media - Recurrent ACS Pearls - Recurrent ACS Approach to accelerated CAD and/or CAD in the young: Causes of MI in young patients can be divided into four groups, although a considerable overlap exists between all groups. (1) atheromatous CAD, (2) non-atheromatous process such as spontaneous coronary artery dissection, vasculitides such as Takayasu disease, (3) hypercoagulable states leading to recurrent arterial and venous thrombosis and/or thromboembolism, and (4) recreational drug use. Clinical Presentation of Takayasu and prevalence of cardiac involvement: Takayasu's arteritis is classified as a large-vessel vasculitis because it primarily affects the aorta and its primary branches. It has a worldwide distribution; however, the greatest prevalence is seen in Asia. Women are affected in 80 to 90 percent of cases, with an age of onset that is usually between 10 and 40 years. Management of Takayasu arteritis: As for systemic anti-inflammatory therapy, the mainstay of treatment would be systemic glucocorticoids guided by the care of a rheumatologist. A steroid sparing agent may be given in conjunction for long term suppressive therapy to achieve longer-term disease control. The choice of additional agents depends on several factors including considerations regarding comorbidities, a patient's plans for conceiving a child, cost of treatments, and availability of specific agents. Options include methotrexate, azathioprine as well as mycophenolate. There are also growing studies into anti-TNF-alpha agents such as etanercept or infliximab. Show Notes - Recurrent ACS

Concussion A concussion, also known as minor or mild traumatic brain injury (mTBI), results from head trauma causing blunt injury to the brain. Clinical Presentation Labs, Studies, and Physical Exam Findings Treatment Post-concussion Syndrome (PCS) Post-concussion syndrome (PCS) is th set o symptoms that can persist for an extended period after a concussion. Clinical Presentation […] The post 118: Brain Trauma & Memorizing Medication tip appeared first on Physician Assistant Exam Review.

In this episode, we cover the following:What is Slipped Capital Femoral Epiphysis (SCFE)?What are some risk factors for developing this?What do we look for in a patient's clinical presentation?How is this identified in imaging?Support the showThe purpose of this podcast is to provide useful, condensed information for exhausted, time-crunched Physical Therapists and Student Physical Therapists who looking to build confidence in their foundational knowledge base and still have time to focus on other important aspects of life. Hit follow to make sure you never miss an episode. Have questions? Want to connect? Contact me at ptsnackspodcast@gmail.com or check out more at ptsnackspodcast.com. On Instagram? Check out the unique content on @dr.kasey.hankins! Need CEUs but low on time and resources? Go to https://www.medbridgeeducation.com/pt-snacks-podcast for over 40% off a year subscription. Use the promo code PTSNACKSPODCAST. This is an affiliate link, but I wouldn't recommend MedBridge if I didn't think they offered value. Willing to support monetarily? Follow the link below to help me continue to create free content. You can also support the show by sharing the word about this show with someone you think would benefit from it.

Dr. Joe Holley joins us on the show this week to share some clinical information with the podcast. He starts off with an update on recent Paragon Medical Group training programs around the country. Then we shift gears into some information on epidemiology issues around the country.

In this episode, Kyle Molina, PharmD, BCIDP, provides an overview of treatment of skin and soft tissue infections (SSTIs) and challenges in practice. Listen as he gives perspectives on:Guideline recommendations for treatment of purulent and nonpurulent SSTIsLogistical challenges with IV and oral antibioticsPros and cons of various locations of careData supporting the safety and efficacy of long-acting lipoglycopeptides for treatment of SSTIsUse of long-acting lipoglycopeptides in special populations of interest, including patients with obesity, diabetes, and injection drug useOverall place in therapy of long-acting lipoglycopeptides for SSTIs Faculty:Kyle Molina, PharmD, BCIDPInfectious Diseases Clinical PharmacistScripps Green HospitalLa Jolla, CaliforniaLink to full program: CCO: https://bit.ly/3J4mg8hProCE: https://bit.ly/3P0vB4E

In this episode, Martin Krsak, MD, MSc, FASAM, provides background and context on skin and soft tissue infections. Listen as he gives perspectives on:Epidemiology and clinical outcomesEconomic impactBacterial etiologyImportance of appropriate antimicrobial prescribingClinical presentationSeverity classification and distinction between purulent and nonpurulent infectionsRole of incision and debridement vs antimicrobial managementComplications to be ruled out prior to treatmentFaculty:Martin Krsak, MD, MSc, FASAMAssociate Professor of MedicineDivision of Infectious Diseases University of Colorado School of MedicineDenver, ColoradoLink to full program: CCO: https://bit.ly/3J4mg8hProCE: https://bit.ly/3P0vB4E

The fundamentals of what you need for your patient encounters and board exams. In this episode we'll discuss a little epidemiology and pathophys, but focus heavily on the clinical presentation and workup. Part 2 will come out soon and focus on the management of systemic sclerosis. Thank you for taking a couple minutes to do the survey :) Survey link here: https://docs.google.com/forms/d/e/1FAIpQLSd6QbrO0kJDzRE8t4fZPIFw1CA9nTw6Qk3Z1FVmCRpt8EdLSg/viewform?usp=sf_link

In today's episode 286, T1 Nerve Root Compression Clinical Presentation (REVISITED) I review the following:1. Pain pattern of a T1 NRC.2. Dermatomal pattern.3. Muscle groups involved.4. Deep tendon reflex affected.5. "Look-a-like" diagnoses.6. Tips to consider during your evaluation and so much more!(Video) T1 NRC evaluation of a patient(-->Get your Saunder's Cervical Traction HERE!)Welcome to our new sponsor!  Chattanooga.  To check out all they have to offer, trial modalities, have your questions answered about shockwave therapy, high level laser, radial pressure wave, connect with them HERE!Want to join the OEP community? Click HERE to jump onto our email list. SUBSCRIBE at the bottom of the page.Ask me your ortho evaluation questions and I will answer them on the show: paul@orthoevalpal.comCome visit our WEBSITE!! Click HERE to check it outGet our downloadable 1.5 hour shoulder anatomy with cadaver dissection lectureGet our downloadable 7.5 hour cervical and lumbar continuing ed courseGet our downloadable 6.0 hour shoulder continuing ed courseBe sure to "follow" us on our new Facebook PageI finally made it to Instagram. Stop by and check us outAre you looking for One on one Coaching? We have it!Be sure to check out our 500+ videos on our YouTube Channel called Ortho Eval Pal with Paul Marquis#T1 #cervicalherniateddisc #nerverootcompression #ptevaluation  #orthopedicevaluation #OrthoEvalPal #Orthopedics #physicaltherapy #physicaltherapytests #athletictraining #occupationaltherapy #chiropractic Support the show Thanks for listening! If you like our podcast, be sure to check out more of our great content at OrthoEvalPal.com, Instagram and Youtube. We'd love a rating or review on your podcast platform. And, as always, be kind to each other and take care!!

In today's episode 285, C8 Nerve Root Compression Clinical Presentation (REVISITED) I review the following:1. Pain pattern of a C8 NRC.2. Dermatomal pattern.3. Muscle groups involved.4. Deep tendon reflex affected.5. "Look-a-like" diagnoses.6. Tips to consider during your evaluation and so much more!C7 evaluation (demonstration, non patient)(-->Get your Saunder's Cervical Traction HERE!)Welcome to our new sponsor!  Chattanooga.  To check out all they have to offer, trial modalities, have your questions answered about shockwave therapy, high level laser, radial pressure wave, connect with them HERE!Want to join the OEP community? Click HERE to jump onto our email list. SUBSCRIBE at the bottom of the page.Ask me your ortho evaluation questions and I will answer them on the show: paul@orthoevalpal.comCome visit our WEBSITE!! Click HERE to check it outGet our downloadable 1.5 hour shoulder anatomy with cadaver dissection lectureGet our downloadable 7.5 hour cervical and lumbar continuing ed courseGet our downloadable 6.0 hour shoulder continuing ed courseBe sure to "follow" us on our new Facebook PageI finally made it to Instagram. Stop by and check us outAre you looking for One on one Coaching? We have it!Be sure to check out our 500+ videos on our YouTube Channel called Ortho Eval Pal with Paul Marquis#c8 #cervicalherniateddisc #nerverootcompression #ptevaluation  #orthopedicevaluation #OrthoEvalPal #Orthopedics #physicaltherapy #physicaltherapytests #athletictraining #occupationaltherapy #chiropractic  Support the show Thanks for listening! If you like our podcast, be sure to check out more of our great content at OrthoEvalPal.com, Instagram and Youtube. We'd love a rating or review on your podcast platform. And, as always, be kind to each other and take care!!

In today's episode 284, C7 Nerve Root Compression Clinical Presentation (REVISITED) I review the following:1. Pain pattern of a C7 NRC.2. Dermatomal pattern.3. Muscle groups involved.4. Deep tendon reflex affected.5. "Look-a-like" diagnoses.6. Tips to consider during your evaluation and so much more!(Video) C7 NRC eval of a Patient(Video) C7 NRC eval of a Patient(-->Get your Saunder's Cervical Traction HERE!)Welcome to our new sponsor!  Chattanooga.  To check out all they have to offer, trial modalities, have your questions answered about shockwave therapy, high level laser, radial pressure wave, connect with them HERE!Want to join the OEP community? Click HERE to jump onto our email list. SUBSCRIBE at the bottom of the page.Ask me your ortho evaluation questions and I will answer them on the show: paul@orthoevalpal.comCome visit our WEBSITE!! Click HERE to check it outGet our downloadable 1.5 hour shoulder anatomy with cadaver dissection lectureGet our downloadable 7.5 hour cervical and lumbar continuing ed courseGet our downloadable 6.0 hour shoulder continuing ed courseBe sure to "follow" us on our new Facebook PageI finally made it to Instagram. Stop by and check us outAre you looking for One on one Coaching? We have it!Be sure to check out our 500+ videos on our YouTube Channel called Ortho Eval Pal with Paul Marquis#c7 #cervicalherniateddisc #nerverootcompression #ptevaluation  #orthopedicevaluation #OrthoEvalPal #Orthopedics #physicaltherapy #physicaltherapytests #athletictraining #occupationaltherapy #chiropractic Support the show Thanks for listening! If you like our podcast, be sure to check out more of our great content at OrthoEvalPal.com, Instagram and Youtube. We'd love a rating or review on your podcast platform. And, as always, be kind to each other and take care!!

In today's episode 283, C6 Nerve Root Compression Clinical Presentation (REVISITED) I review the following:1. Pain pattern of a C6 NRC.2. Dermatomal pattern.3. Muscle groups involved.4. Deep tendon reflex affected.5. "Look-a-like" diagnoses.6. Tips to consider during your evaluation and so much more!(Video) C6 NRC eval with patient(Video) C6 Weakness in patient(-->Get your Saunder's Cervical Traction HERE!)Welcome to our new sponsor!  Chattanooga.  To check out all they have to offer, trial modalities, have your questions answered about shockwave therapy, high level laser, radial pressure wave, connect with them HERE!Want to join the OEP community? Click HERE to jump onto our email list. SUBSCRIBE at the bottom of the page.Ask me your ortho evaluation questions and I will answer them on the show: paul@orthoevalpal.comCome visit our WEBSITE!! Click HERE to check it outGet our downloadable 1.5 hour shoulder anatomy with cadaver dissection lectureGet our downloadable 7.5 hour cervical and lumbar continuing ed courseGet our downloadable 6.0 hour shoulder continuing ed courseBe sure to "follow" us on our new Facebook PageI finally made it to Instagram. Stop by and check us outAre you looking for One on one Coaching? We have it!Be sure to check out our 500+ videos on our YouTube Channel called Ortho Eval Pal with Paul Marquis#c6 #cervicalherniateddisc #nerverootcompression #ptevaluation  #orthopedicevaluation #OrthoEvalPal #Orthopedics #physicaltherapy #physicaltherapytests #athletictraining #occupationaltherapy #chiropractic  Support the show Thanks for listening! If you like our podcast, be sure to check out more of our great content at OrthoEvalPal.com, Instagram and Youtube. We'd love a rating or review on your podcast platform. And, as always, be kind to each other and take care!!

In today's episode 282, C5 Nerve Root Compression Clinical Presentation (REVISITED) I review the following:1. Pain pattern of a C5 NRC.2. Dermatomal pattern.3. Muscle groups involved.4. Deep tendon reflex affected.5. "Look-a-like" diagnoses.6. Tips to consider during your evaluation and so much more!(Video) C5 NRC patient(Video) Shingles affecting a C5 nerve root patient(Video) C5 Herniated disc patient eval(-->Get your Saunder's Cervical Traction HERE!)Welcome to our new sponsor!  Chattanooga.  To check out all they have to offer, trial modalities, have your questions answered about shockwave therapy, high level laser, radial pressure wave, connect with them HERE!Want to join the OEP community? Click HERE to jump onto our email list. SUBSCRIBE at the bottom of the page.Ask me your ortho evaluation questions and I will answer them on the show: paul@orthoevalpal.comCome visit our WEBSITE!! Click HERE to check it outGet our downloadable 1.5 hour shoulder anatomy with cadaver dissection lectureGet our downloadable 7.5 hour cervical and lumbar continuing ed courseGet our downloadable 6.0 hour shoulder continuing ed courseBe sure to "follow" us on our new Facebook PageI finally made it to Instagram. Stop by and check us outAre you looking for One on one Coaching? We have it!Be sure to check out our 500+ videos on our YouTube Channel called Ortho Eval Pal with Paul Marquis#c5 #cervicalherniateddisc #nerverootcompression #ptevaluation  #orthopedicevaluation #OrthoEvalPal #Orthopedics #physicaltherapy #physicaltherapytests #athletictraining #occupationaltherapy #chiropractic  Support the show Thanks for listening! If you like our podcast, be sure to check out more of our great content at OrthoEvalPal.com, Instagram and Youtube. We'd love a rating or review on your podcast platform. And, as always, be kind to each other and take care!!

Commentary by Associate Editor Sean Pinney

In this episode, Alba Azola, MD, and Monica Verduzco-Gutierrez, MD, discuss diagnosis and management of long COVID, including: Definitions of post COVID conditionsDiagnosis, including symptoms and clinical presentationEpidemiologyRisk factorsPossible treatment optionsClinical guidance statementsPresenters:Alba Azola, MDAssistant ProfessorDepartment of Physical Medicine and RehabilitationJohns HopkinsCo-DirectorJohns Hopkins Post Acute COVID Team ClinicBaltimore, MarylandMonica Verduzco-Gutierrez, MDProfessor and Distinguished ChairDepartment of Rehabilitation MedicineUniversity of Texas Health Science Center at San AntonioDirector, UT Health COVID-19 Recovery ClinicDepartment of Rehab MedicineUT Health San AntonioSan Antonio, TexasLink to full program:https://bit.ly/3Gn4tXOLinks to Consensus Guidance Statements on Assessment and Treatment of Post-Acute Sequelae of COVID-19:Autonomic Dysfunction:https://bit.ly/3GHeUGYCardiovascular Complications:https://bit.ly/3CmupkXCognitive Symptoms:https://bit.ly/3X9tnkwFatigue:https://bit.ly/3ihiLRQRespiratory Sequelae: https://bit.ly/3IrUkMc

(EMBARGO UNTIL MONDAY) Adequate Dosing of Hydroxychloroquine: Are Patients Getting Enough? Dr. Sheila Reyes, The Phillipines Abstract 1654. A Year in Review Dr. Jack Cush, Philadelphia Differences in Clinical Presentation and Outcomes of Early vs Late Onset PsA Dr. Olga Petryna, New York Abstract 0377 mTORC1 as a Driver of Inflammation in sJIA Connecting Pathogens of sJIA and MAS Dr. Olga Petryna, New York Abstract 0004 Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor Dr. Sims discusses abstract 0199 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0199: Izokibep, a Novel IL-17A Inhibitor, Improves Patient-reported Outcomes – 16-Week Results from a Placebo-controlled Phase 2 Study in Patients with Active Psoriatic Arthritis The CONSUL Trial Dr. Sheila Reyes, The Phillipines Abstract 0526 What's Happening on the Hill? Dr. Rachel Tate talks with Dr. Angus Worthing about ACR22 Convergence Session # 12S119 about legislative updates.

Commentary by Dr. Tazeen Jafar

We are very excited to bring you the top papers from the 2022 Society for Clinical Vascular Surgery meeting. This episode features 3 papers, discussed by the primary author with commentary provided by Dr. Caron Rockman, President of the SCVS, Professor of Surgery at NYU, and program director of Vascular Surgery training programs. Vice-President Dr. Ashraf Mansour, Professor and Chair of Surgery at Michigan State University, and Dr. Jean Bismuth, SCVS Secretary, from Houston, Texas. Clinical Presentation, Operative Management and Long-term Outcome of Rupture Following Previous Abdominal Aortic Aneurysm Repair Discussed by: Dr. Indrani Sen Authors: Indrani Sen, Irina Kanzafarova, Jennifer Yonkus, Bernardo Mendes, Jill Colglazier, Fahad Shuja, Randall DeMartino, Manju Kalra, Todd Rasmussen Utilization of Thromboelastography with Platelet Mapping Assay to Predict Graft Thrombosis in Lower Extremity Revascularization Discussed by: Dr. Monica Majumdar Authors: Monica Majumdar MD MPH, Zach M Feldman MD, Imani McElroy MD, Natalie Sumetsky MS, Harold D Waller MD, Srihari Lella MD, Ryan P Hall MD, Young Kim MD, Kathryn Nuzzolo BS, Amanda Kirshkaln MS, David Chang PhD MPH MBA, Jessica Cardenas PhD, Eric Grabowski MD, Rushad Patell MD, Matthew Eagleton MD, Anahita Dua MD MS MBA  Outcomes Of Upper Extremity Vs. Transfemoral Access For Fenestrated-branched Endovascular Aortic Repair (FB-EVAR) Discussed by: Dr. Khalil Chamseddin Authors: ​​Khalil Chamseddin MD, Carlos H. Timaran MD, Gustavo S. Oderich MD, Emanuel R. Tenorio MD, PhD, Mark A. Farber MD, F. Ezequiel Parodi MD, Darren B. Schneider MD, Andres Schanzer MD, Adam W. Beck MD, Matthew P. Sweet MD, Sara L. Zettervall MD, Bernardo Mendes MD , Matthew J. Eagleton MD, on behalf of the U.S. Aortic Research Consortium Follow us on twitter at: @audiblebleeding Dr. Amanda Fobare: @amandafobare Dr. Caron Rockman: @CaronRockman Dr. Jean Bismuth: @Jean Bismuth Dr. Indrani Sen: @IndraniSenvasc Dr. Monica Majumdar: @Monica_Majumdar

In this episode, Dr. Michael Shapiro and Dr. Pam Taub discuss the clinical presentation, natural history, and diagnosis of familial hypercholesterolemia.

Bladder carcinoma   Bladder cancer is 3x as likely in men than women Transitional cell carcinoma is > 90% of bladder cancers. Risk Factors Smoking!! Chronic irritation Clinical Presentation –  Bloody urine is the most common presenting symptom Pyuria Dysuria Labs, Studies and Physical Exam Findings   Urinalysis shows hematuria   U/S, CT, MRI   […] The post S2 E097 Genitourinary Neoplasms and a small hack to help you through school appeared first on Physician Assistant Exam Review.

Cryptorchidism One or both of the testes absent from the scrotum   Risk factors   Premature birth   Low birth weight Clinical Presentation   Routine pediatric exam Labs, Studies and Physical Exam Findings –  Provider is unable to palpate one or both testicles –  U/S   MRI Treatment Initially watchful waiting. The majority will descend […] The post S2 E095 Urology Problems & how to beat the PANCE appeared first on Physician Assistant Exam Review.

Not on GU? Listen to this one anyway. There’s so much to unpack here. One of the best episodes I’ve ever recorded. It doesn’t matter if your on GU or not. Give it a listen. Erectile dysfunction Clinical Presentation   Usually a routine physical exam and direct questioning Labs, Studies and Physical Exam Findings   […] The post S2 E094 Male genitalia, Studying for test questions and understanding the PANCE appeared first on Physician Assistant Exam Review.

In this VETgirl online veterinary continuing education podcast, we discuss the clinical presentation, cardiovascular findings, etiology, and outcome of myocarditis in dogs. Myocarditis, or inflammation of the myocardium, is not well studied in dogs but can occur secondary to infectious and noninfectious etiologies. Infectious etiologies previously reported in dogs include trypanosomiasis, leishmaniasis, parvovirus, toxoplasmosis, neosporosis, borreliosis, ehrlichiosis, leptospirosis and bartonellosis. Drugs, toxins, immune-mediated disease, trauma, heat stroke, shock, and idiopathic account for the reported noninfectious causes. Definitive diagnosis requires histopathology, which would mean the need for endomyocardial biopsy in living patients – which I'll admit, I'm scared to do - it's not exactly a procedure without risk. As a result, antemortem histopathology is not commonly obtained in dogs and diagnosis is usually presumptive based on the subjective clinical picture. Standard criteria for antemortem diagnosis have not been established in dogs.Sponsored By: IndeVets

PDF Notes for Episode on Clinical Presentation and Diagnosis of Esophageal Cancer.

Dr. Waheed interviews Drs. LoRusso and Statland on their article, Guidelines on clinical presentation and management of nondystrophic myotonias.